High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
Journal Information
Full Title: J Exp Clin Cancer Res
Abbreviation: J Exp Clin Cancer Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe studies involving animals and human participants were reviewed and approved by the Ethical Committee of Beijing Tsinghua Changgung Hospital and National Cancer Center (Ethical approval number: NCC2021C-535). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported by grants from National Key R&D Program of China (Grant No.2022YFE0200800) awarded to Nianzeng Xing, Research Fund for Tumors of Urinary System treatment in China (Grant No. 020) awarded to Fangming Wang."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025